CIK 0001846253
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
OmniAb, Inc.
Sign in to watch- Ticker
- OABI
- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 510-250-7800
- Business address
- 5980 HORTON STREET, SUITE 600, EMERYVILLE, CA, 94608
- Former names
- Avista Public Acquisition Corp. II
Securities
- OABI Common Stock Nasdaq
- OABIW Warrant Nasdaq
- 4 Grant or award Director acquired 53,308 shares (grant or award)
- 4/A Derivatives Options or other derivatives
- 4 Grant or award Director acquired 53,308 shares (grant or award)
- 4 Grant or award EVP, Finance and CFO acquired 139,504 shares (grant or award)
- 4 Grant or award Berkman Charles S acquired 46,864 shares (grant or award)
- 4 Grant or award President & CEO acquired 79,665 shares (grant or award)
- 4 Shares withheld for taxes Berkman Charles S gave up 6,518 shares (to pay taxes)
- 4 Shares withheld for taxes President & CEO gave up 11,624 shares (to pay taxes)
- 4 Open-market buy President & CEO bought 150,000 shares at $3.77 ($564,765)
- 4 Other disposition Director disposed of 15,817,934 shares (other)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 22,250 shares at $3.75 ($83,527)
- 4 Shares withheld for taxes Berkman Charles S gave up 10,580 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Finance and CFO gave up 6,733 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes President & CEO gave up 17,266 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Open-market buy President & CEO bought 300,000 shares at $3.39 ($1,016,340)
Page 7 of 9 · 174 filings